(Q35890799)

11 August 2017

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis (English)

1 reference

11 August 2017

anti-retroviral agent

0 references

0 references

Stewart Reid

18

0 references

Nesri Padayatchi

object named as

Nesri Padayatchi

16

0 references

N. Kumarasamy

15

object named as

N Kumarasamy

1 reference

11 August 2017

7

Anne F Luetkemeyer

1 reference

11 August 2017

30

Ian Sanne

1 reference

11 August 2017

24

Jean W Pape

1 reference

11 August 2017

1

Diane V Havlir

1 reference

11 August 2017

5

Susan Swindells

1 reference

11 August 2017

21

Peter Mugyenyi

1 reference

11 August 2017

13

Valdilea G Veloso

1 reference

11 August 2017

11

Mina C Hosseinipour

1 reference

11 August 2017

3

Prudence Ive

1 reference

11 August 2017

19

James Hakim

1 reference

11 August 2017

4

Johnstone Kumwenda

1 reference

11 August 2017

12

Umesh Lalloo

1 reference

11 August 2017

28

Fred Sawe

1 reference

11 August 2017

26

Aida Asmelash

1 reference

11 August 2017

6

Sarojini S Qasba

1 reference

11 August 2017

8

Evelyn Hogg

1 reference

11 August 2017

Michelle A Kendall

2

1 reference

11 August 2017

James F Rooney

9

1 reference

11 August 2017

Xingye Wu

10

1 reference

11 August 2017

Fatuma F Some

14

1 reference

11 August 2017

Breno R Santos

17

1 reference

11 August 2017

Lerato Mohapi

20

1 reference

11 August 2017

Jorge Sanchez

22

1 reference

11 August 2017

Javier R Lama

23

1 reference

11 August 2017

Alejandro Sanchez

25

1 reference

11 August 2017

Evans Moko

27

1 reference

11 August 2017

Janet Andersen

29

1 reference

11 August 2017

AIDS Clinical Trials Group Study A5221

31

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

The New England Journal of Medicine

11 August 2017

1 reference

11 August 2017

365

1 reference

11 August 2017

16

1 reference

11 August 2017

1482-1491

1 reference

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

HIV infection-related tuberculosis: clinical manifestations and treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

HIV infection-associated tuberculosis: the epidemiology and the response

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Timing of initiation of antiretroviral drugs during tuberculosis therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Novel and improved technologies for tuberculosis diagnosis: progress and challenges

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

A Multiple Testing Procedure for Clinical Trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3327101

24 September 2018

Identifiers

DOI

10.1056/NEJMOA1013607

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22010914

1 reference